Synthesis of microtubule-interfering halogenated noscapine analogs that perturb mitosis in cancer cells followed by cell death

被引:94
作者
Aneja, Ritu
Vanyapandu, Surya N.
Lopus, Manu
Viswesarappa, Vijaya G.
Dhiman, Neerupma
Verma, Akhilesh
Chandra, Ramesh
Panda, Dulal
Joshi, Harish C.
机构
[1] Emory Univ, Sch Med, Dept Cell Biol, Lab Drug Discovery & Res, Atlanta, GA 30322 USA
[2] Indian Inst Technol, Sch Biosci & Bioengn, Bombay, Maharashtra, India
[3] Univ Delhi, BR Ambedkar Ctr Biomed Res, Delhi 110007, India
关键词
cell cycle; mitotic arrest; anticancer; tubulin-binding;
D O I
10.1016/j.bcp.2006.05.004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We have previously identified the naturally occurring non-toxic antitussive phthalideiso-quinoline alkaloid, noscapine as a tubulin-binding agent that arrests mitosis and induces apoptosis. Here we present high-yield efficient synthetic methods and an evaluation of anticancer activity of halogenated noscapine analogs. our results show that all analogs display higher tubulin-binding activity than noscapine and inhibit proliferation of human cancer cells (MCF-7, MDA-MB-231 and CEM). Surprisingly, the bromo-analog is similar to 40-fold more potent than noscapine in inhibiting cellular proliferation of MCF-7 cells. The ability of these analogs to inhibit cellular proliferation is mediated by cell cycle arrest at the G(2)/M phase, in that all analogs except 9-iodonoscapine, caused selective mitotic arrest with a higher efficiency than noscapine followed by apoptotic cell death as shown by immunofluorescence and quantitative FACS analyses. Furthermore, our results reveal the appearance of numerous fragmented nuclei as evidenced by DAPI staining. Thus, our data indicate a great potential of these compounds for studying microtubule-mediated processes and as chemotherapeutic agents for the management of human cancers. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:415 / 426
页数:12
相关论文
共 43 条
  • [1] Identification of novel and improved antimitotic agents derived from noscapine
    Anderson, JT
    Ting, AE
    Boozer, S
    Brunden, KR
    Crumrine, C
    Danzig, J
    Dent, T
    Faga, L
    Harrington, JJ
    Hodnick, WF
    Murphy, SM
    Pawlowski, G
    Perry, R
    Raber, A
    Rundlett, SE
    Stricker-Krongrad, A
    Wang, JM
    Bennani, YL
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (23) : 7096 - 7098
  • [2] Discovery of S-phase arresting agents derived from noscapine
    Anderson, JT
    Ting, AE
    Boozer, S
    Brunden, KR
    Danzig, J
    Dent, T
    Harrington, JJ
    Murphy, SM
    Perry, R
    Raber, A
    Rundlett, SE
    Wang, JM
    Wang, N
    Bennani, YL
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (08) : 2756 - 2758
  • [3] MECHANISM OF COLCHICINE BINDING TO TUBULIN - TOLERANCE OF SUBSTITUENTS IN RING-C' OF BIPHENYL ANALOGS
    ANDREU, JM
    GORBUNOFF, MJ
    MEDRANO, FJ
    ROSSI, M
    TIMASHEFF, SN
    [J]. BIOCHEMISTRY, 1991, 30 (15) : 3777 - 3786
  • [4] Rational design of the microtubule-targeting anti-breast cancer drug EM015
    Aneja, R
    Lopus, M
    Zhou, J
    Vangapandu, SN
    Ghaleb, A
    Yao, J
    Nettles, JH
    Zhou, BF
    Gupta, M
    Panda, D
    Chandra, R
    Joshi, HC
    [J]. CANCER RESEARCH, 2006, 66 (07) : 3782 - 3791
  • [5] Drug-resistant T-lymphoid tumors undergo apoptosis selectively in response to an antimicrotubule agent, EM011
    Aneja, R
    Zhou, J
    Vangapandu, SN
    Zhou, BF
    Chandra, R
    Joshi, HC
    [J]. BLOOD, 2006, 107 (06) : 2486 - 2492
  • [6] CAINELLI G, 1976, SYNTHESIS-STUTTGART, P472
  • [7] Microtubule-interacting drugs for cancer treatment
    Checchi, PM
    Nettles, JH
    Zhou, J
    Snyder, JP
    Joshi, HC
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2003, 24 (07) : 361 - 365
  • [8] The taxanes: an update
    Crown, J
    O'Leary, M
    [J]. LANCET, 2000, 355 (9210) : 1176 - 1178
  • [9] PHARMACOKINETIC PROPERTIES OF NOSCAPINE
    DAHLSTROM, B
    MELLSTRAND, T
    LOFDAHL, CG
    JOHANSSON, M
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 22 (06) : 535 - 539
  • [10] Dey B. B., 1935, J INDIAN CHEM SOC, V12, P526